Vimarsana
Biggest News Aggregation in the World

Page 4 - Arch Pathol Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arch Pathol Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arch Pathol Lab Today - Breaking & Trending Today

Pathomation announces CE-IVD mark for clinical diagnostic use of vendor neutral PMA.core software - Vimarsana News

Pathomation announces CE-IVD mark for clinical diagnostic use of vendor neutral PMA.core software

Antwerp, Belgium, May 25th 2022 (PRWEB) May 27, 2022 -- Pathomation, a leading pioneer in universal digital pathology software solutions, is excited to

Source: prweb.com
Enhertu granted Breakthrough Therapy Designation in the US for patients with HER2-low metastatic breast cancer - Vimarsana News

Enhertu granted Breakthrough Therapy Designation in the US for patients with HER2-low metastatic breast cancer

AstraZeneca and Daiichi Sankyo’s Enhertu has been granted Breakthrough Therapy Designation in the US for the treatment of adult patients with unresectable or...

The Different Types of Microscopy Used in Histology - Vimarsana News

The Different Types of Microscopy Used in Histology

Histology is the microscopic study of cells and tissues and plays a central role in disease diagnosis. Through the identification of characteristic features in tissue structures, it is possible to diagnose cancers and many other diseases by comparing changes in the cellular structure between healthy and diseased tissues.

HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS in Lung Cancer - Vimarsana News

HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS in Lung Cancer

07.03.2022 - HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 07, 2022 (GLOBE NEWSWIRE) - (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has received a US$15 million milestone payment from AstraZeneca PLC (“AstraZeneca”) ...

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Enhertu improves PFS and OS in HER2-low BC - Vimarsana News

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Enhertu improves PFS and OS in HER2-low BC

Investegate announcements from AstraZeneca PLC, Enhertu improves PFS and OS in HER2-low BC